Sarah N Hilmer Selected Research

Polypharmacy

1/2022	Preclinical frailty assessments: Phenotype and frailty index identify frailty in different mice and are variably affected by chronic medications.
1/2022	Geriatric medicine and health care for older people in Australia.
1/2022	Comparing Effects of Polypharmacy on Inflammatory Profiles in Older Adults and Mice: Implications for Translational Aging Research.
6/2021	Development and validation of a frailty index based on data routinely collected across multiple domains in NSW hospitals.
1/2021	Deprescribing in the Older Patient: A Narrative Review of Challenges and Solutions.
1/2021	COVID-19 Pandemic: Considerations for Safe Medication Use in Older Adults with Multimorbidity and Polypharmacy.
1/2021	Chronic Polypharmacy with Increasing Drug Burden Index Exacerbates Frailty and Impairs Physical Function, with Effects Attenuated by Deprescribing, in Aged Mice.
1/2021	Attitudes toward deprescribing among adults with heart failure with preserved ejection fraction.
12/2020	Implementation of the Goal-directed Medication review Electronic Decision Support System (G-MEDSS)© into home medicines review: a protocol for a cluster-randomised clinical trial in older adults.
10/2020	Withdrawal of antihypertensive drugs in older people.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sarah N Hilmer Research Topics

Disease

30	Frailty 01/2022 - 03/2009
23	Dementia (Dementias) 01/2022 - 03/2011
18	Cognitive Dysfunction 01/2021 - 02/2009
11	Drug-Related Side Effects and Adverse Reactions 01/2022 - 10/2004
8	Pain (Aches) 11/2016 - 01/2010
5	Atrial Fibrillation 11/2016 - 03/2009
4	Stroke (Strokes) 10/2020 - 01/2016
4	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 01/2006
4	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 10/2013
3	Heart Failure 10/2022 - 10/2020
3	Delirium 01/2022 - 01/2021
3	Hemorrhage 01/2019 - 01/2016
3	Sepsis (Septicemia) 05/2014 - 01/2009
3	Body Weight (Weight, Body) 05/2014 - 01/2006
2	Hypertension (High Blood Pressure) 10/2020 - 01/2019
2	Sleep Initiation and Maintenance Disorders (Insomnia) 11/2016 - 12/2015
2	Hyperlipidemias (Hyperlipidemia) 10/2010 - 12/2006
2	Hypoxia (Hypoxemia) 10/2007 - 10/2007
2	Atherosclerosis 12/2006 - 12/2005
1	Inflammation (Inflammations) 01/2022
1	Nausea 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Clostridium Infections 01/2021
1	COVID-19 01/2021
1	Chronic Renal Insufficiency 10/2020
1	Myocardial Infarction 10/2020
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2019
1	Hip Fractures (Intertrochanteric Fractures) 01/2019
1	Confusion (Bewilderment) 04/2018
1	Acute Coronary Syndrome 01/2017
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2016
1	Tuberculosis (Tuberculoses) 02/2016
1	Necrosis 02/2016
1	Disorders of Excessive Somnolence (Hypersomnia) 12/2015
1	Sleepiness 12/2015
1	Urinary Incontinence 08/2015
1	Myocardial Ischemia (Ischemic Heart Diseases) 08/2015

Drug/Important Bio-Agent (IBA)

22	Pharmaceutical PreparationsIBA 01/2022 - 10/2008
8	5-methoxy-methylindoleacetic acid (DBI)IBA 01/2022 - 05/2011
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2019 - 03/2013
7	Cholinergic Antagonists (Anticholinergics)IBA 01/2019 - 04/2012
7	Hypnotics and Sedatives (Sedatives)IBA 01/2019 - 04/2012
6	Analgesics (Analgesic Drugs)IBA 09/2016 - 03/2011
4	Biological ProductsIBA 01/2022 - 05/2014
3	AnticoagulantsIBA 01/2019 - 01/2016
3	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2016 - 01/2015
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2019 - 01/2018
2	Memantine (Namenda)FDA Link 01/2019 - 01/2018
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2017 - 06/2016
2	Antidepressive Agents (Antidepressants)IBA 06/2016 - 02/2009
2	Opioid Analgesics (Opioids)IBA 12/2015 - 01/2010
2	ORALIT (ORS)IBA 12/2015 - 06/2014
2	Gentamicins (Gentamicin)FDA LinkGeneric 05/2014 - 02/2011
2	Triglycerides (Triacylglycerol)IBA 10/2010 - 01/2009
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 10/2010 - 01/2009
2	pimonidazoleIBA 10/2007 - 10/2007
2	Adenosine Triphosphate (ATP)IBA 10/2007 - 10/2007
2	Oxygen (Dioxygen)IBA 10/2007 - 10/2007
2	CholesterolIBA 01/2006 - 03/2005
1	oxybutynin (Tavor)FDA LinkGeneric 01/2022
1	Digoxin (Digitek)FDA LinkGeneric 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2022
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2022
1	Citalopram FDA LinkGeneric 01/2022
1	CytokinesIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 10/2020
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2019
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2019
1	Alanine Transaminase (SGPT)IBA 07/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2017
1	ibrutinibIBA 11/2016
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2016
1	ResveratrolIBA 03/2016
1	Isoniazid (Ftivazide)FDA LinkGeneric 02/2016
1	Dabigatran FDA Link 01/2016
1	Warfarin (Coumadin)FDA LinkGeneric 01/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	Blood Proteins (Serum Proteins)IBA 01/2016
1	EnzymesIBA 01/2016
1	AlbuminsIBA 01/2016
1	CreatinineIBA 05/2014
1	Risperidone (Risperdal Consta)FDA LinkGeneric 10/2013

Therapy/Procedure

16	Polypharmacy 01/2022 - 10/2004
13	Deprescriptions 10/2022 - 01/2015
7	Therapeutics 01/2021 - 03/2009
4	Activities of Daily Living (ADL) 01/2019 - 02/2014
3	Length of Stay 01/2019 - 06/2016
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2019
2	Pain Management 01/2015 - 03/2011
2	Liver Transplantation 01/2009 - 12/2008
1	Duration of Therapy 01/2022
1	Medication Errors (Medication Error) 01/2022
1	Perioperative Care 01/2022
1	Vascular Surgical Procedures 01/2021
1	Conservative Treatment 01/2019
1	Home Nursing (Nursing, Home) 01/2019
1	Long-Term Care 01/2019
1	Secondary Prevention 01/2017
1	Inappropriate Prescribing 05/2015